Search company, investor...

About G9 Ventures

G9 Ventures delivers high-impact partnerships for exceptional founders. It invests in early-stage companies that empower the consumer to live, look, and feel better. It is based in New York, New York.

Headquarters Location

New York, New York,

United States



Latest G9 Ventures News

Evvy Raises $14M in Series A Funding

Sep 28, 2023

Evvy , a NYC-based startup providing women’s healthcare through biomarker discovery, raised $14M in Series A funding. The round was led by Left Lane Capital, with participation from General Catalyst, Labcorp Venture Fund, RH Capital, Ingeborg Investments, G9 Ventures, Virtue, and Amboy Street Ventures. The company intends to use the funds to scale access to its testing & care platform, leverage AI to discover novel molecular signatures for women’s health diagnostics, and validate improved outcomes in fertility, pregnancy, and beyond. Founded by Priyanka Jain, Laine Bruzek, and Pita Navarro, Evvy provides an at-home vaginal microbiome test to use metagenomic sequencing. Insights from their test led to the expansion of its vaginal health platform, which now brings together testing, precision care, and proactive tracking to give women and people with vaginas the healthcare they deserve. Through it, Evvy is building the real-world datasets necessary to improve health conditions in the female body. For eligible tests, the company also offers clinically-validated integrative prescription treatment programs to improve the vaginal microbiome. Today, the company is also announcing the addition of STI and antibiotic resistance testing as an add-on PCR panel to its Vaginal Health Test. The PCR panel will screen for a range of common sexually transmitted infections including chlamydia, gonorrhea, trichomoniasis, and more. It also identifies the presence of 11 vaginal microbes, similar to a standard vaginitis PCR test offered at doctor’s offices, and 17 antibiotic-resistance genes. All PCR results are returned within three business days, with options for immediate STI treatment prescriptions when necessary. Once full metagenomic sequencing results are ready, Evvy compiles all test data into a cohesive results experience along with a custom plan with clear next steps, science-backed education, and free 1:1 coaching. For eligible tests, Evvy also offers clinically-validated integrative prescription treatment programs to improve the vaginal microbiome. FinSMEs 27/09/2023

G9 Ventures Frequently Asked Questions (FAQ)

  • Where is G9 Ventures's headquarters?

    G9 Ventures's headquarters is located at New York.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.